Health Ahead Comparative Effectiveness Study
William Brandenburg, MD · NCT07669168
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1000000
- US sites recruiting
- 1
- Study start
- June 9, 2026
- Record last updated
- September 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Health Ahead Comparative Effectiveness Study is a pragmatic, parallel-arm interventional platform that systematically compares successive changes to preventive health screening on the path toward a fully automated screening system deployable in any environment, including the most isolated and resource-limited communities. Each change is isolated as a single variable against current practice, and every comparison is evaluated with a common set of engagement, behavior-change, experience, cost, and longitudinal outcome measures, so results accumulate on a consistent yardstick across the life of the platform.
The first comparison evaluates AI-assisted versus human-only interpretation ("reads") of screening data. Subsequent pre-planned comparisons, added by protocol amendment, evaluate static versus interactive personalized report delivery; mobile community versus fixed laboratory screening; and a hybrid medical-droid-plus-human delivery model versus human-only screening.
Being studied: AI-Assisted Screening Interpretation (AI Reads); Human-Only Screening Interpretation
Conditions: Health Services Accessibility; Rural Health; Medically Underserved Area; Preventive Health Services; Patient Participation; Health Behavior; Aging; Cardiovascular Diseases; Metabolic Syndrome; Cognitive Dysfunction; Frailty; Activities of Daily Living; Health Related Quality of Life; Health Equity; Telemedicine
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 years or older
- Willing and able to provide written informed consent, or enrollment with consent of a legally authorized representative
- Willing to participate in longitudinal follow-up.
Exclusion Criteria
- Age under 18 years.
Recruiting US locations
Longevity Metrics
Boulder, CO 80301
Site contact: William Brandenburg, MD · 3035010016 · info@longevitymetrics.org
Study contacts (from the official record)
- William Brandenburg, MD · 13035010016 · info@longevitymetrics.org
Similar studies in Colorado
All heart & blood pressure studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
Aktiia SA
- Location
- Broomfield, CO
- Eligibility basics
- Ages 22–59
- RecruitingHealthy volunteers
Longevity Metrics AI/ML Development Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
100-Year Human Aging Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+